BeStock  
Stocks › Biotechnology › LGND

Ligand Pharmaceuticals LGND

US equityMarket cap rank #1897Biotechnology
$286.85 −$0.09 (-0.03%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $286.85 0.00%
Open$285.21
Prev close$286.94
Day range$282.36 – $291.36
Volume259.8K
Market cap$5.74B
P/E (TTM)115.2
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$78.75M-31.8% YoY
Operating profit-$9.49M-117.5% YoY
Net profit-$28.49M-124.3% YoY
Diluted EPS-$1.43-125.2% YoY
Free cash flow-$57.60M-1,329.7% YoY
Operating cash flow-$27.59M

Revenue, last 8 quarters

$42.8MDec '24$45.3MMar '25$47.6MJun '25$115.5MSep '25$59.7MDec '25$51.7MMar '26$63.7MJun '26$78.7MSep '26

Net profit, last 8 quarters

$-31.1MDec '24$-42.5MMar '25$4.8MJun '25$117.3MSep '25$44.8MDec '25$-13.3MMar '26$48.5MJun '26$-28.5MSep '26

Diluted EPS by quarter

-1.64Dec '24-2.21Mar '250.24Jun '255.68Sep '252.12Dec '25-0.67Mar '262.22Jun '26-1.43Sep '26

Free cash flow by quarter

$27.8MDec '24$-27.5MMar '25$15.6MJun '25$4.7MSep '25$45.3MDec '25$48.5MMar '26$21.4MJun '26$-57.6MSep '26

Annual revenue

$163.6MFY20$241.5MFY21$196.2MFY22$131.3MFY23$167.1MFY24$268.1MFY25

Profitability & balance sheet

Gross margin95.2%
Operating margin14.4%
Net margin20.3%
Return on equity5.4%
Return on assets2.8%
Return on invested capital1.9%
Current ratio1.22
Liabilities / assets57.0%
Cash & investments$474.89M
Total debt$1.15B
Net cash (debt)-$674.76M
Free cash flow / sales22.6%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $78.75M $63.69M $51.72M $268.09M $59.67M
Total Operating Revenue $78.75M $63.69M $51.72M $268.09M $59.67M
Cost of Revenue $2.65M $3.21M $3.27M $14.55M $2.99M
Gross Profit $76.10M $60.48M $48.45M $253.54M $56.67M
Operating Expense $85.59M $51.89M $31.08M $206.34M $36.63M
Selling and Admin Expenses $72.62M $29.12M $20.84M $92.45M $25.03M
-General & Admin Expense $72.62M $29.12M $20.84M $92.45M $25.03M
Research & Development $2.77M $14.67M $2.15M $81.18M $3.51M
Depreciation & Amortization & Depletion $10.21M $8.10M $8.10M $32.71M $8.10M
-Depreciation & Amortization $10.21M $8.10M $8.10M $32.71M $8.10M
Operating Profit -$9.49M $8.59M $17.37M $47.20M $20.04M
Net Non-Operating Interest Income (Expense) $2.59M $5.55M $4.91M $8.94M $4.61M
Non-Operating Interest Income $5.49M $7.30M $6.66M $13.66M $6.39M
Non-Operating Interest Expense $2.90M $1.75M $1.75M $4.72M $1.79M
Other Income (Expense) -$37.20M $50.16M -$46.54M $102.82M $32.13M
Gain on Sale of Security -$3.82M $11.75M $3.87M $18.43M $22.06M
Earnings from Equity Interest -$35.73M $35.73M -$49.23M $90.67M $14.78M
Special Income (Charges) -$6.27M – – -$6.20M -$4.72M
-Less:Restructuring and Mergern & Acquisition $6.27M – – – –
Other Non-Operating Income (Expenses) $8.61M $2.68M -$1.18M -$89,000.00 $8,000.00
Pretax Profit -$44.09M $64.30M -$24.26M $158.96M $56.78M
Tax -$15.61M $15.80M -$10.91M $34.51M $12.00M
Net Profit -$28.49M $48.51M -$13.35M $124.45M $44.78M
Profit from Continuing Operations -$28.49M $48.51M -$13.35M $124.45M $44.78M
Net Income to Parent Company -$28.49M $48.51M -$13.35M $124.45M $44.78M
Net Income to Common Stockholders -$28.49M $48.51M -$13.35M $124.45M $44.78M
Basic EPS -$1.43 $2.42 -$0.67 $6.44 $2.27
Diluted EPS -$1.43 $2.22 -$0.67 $6.13 $2.12
-Less:Write Off – – – $6.20M $6.20M
-Gain on Sale Of Business – – – $0.00 –
Net Income from Discontinuous Operations – – – $0.00 –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $2.24B $2.19B $1.53B $1.56B $1.56B
Total Current Assets $608.23M $1.46B $865.42M $832.27M $832.27M
Cash and Cash Equivalents & Short-Term Investments $474.89M $1.37B $791.56M $756.31M $756.31M
-Cash and Cash Equivalents $55.96M $1.01B $115.08M $174.93M $174.93M
-Short Term Investments $418.93M $364.04M $676.48M $581.39M $581.39M
Receivables $107.52M $69.92M $54.80M $61.05M $61.05M
-Accounts Receivable $83.22M $67.01M $53.38M $59.60M $59.60M
-Taxes Receivable $24.30M $2.91M $1.42M $1.45M $1.45M
Prepaid Assets $1.60M $1.60M $1.80M – –
Inventory $12.91M $8.66M $11.47M $9.13M $9.13M
Restricted Cash $4.11M – – – –
Other Current Assets $7.21M $6.19M $5.80M $5.79M $5.79M
Total Non-Current Assets $1.63B $728.76M $666.69M $728.37M $728.37M
Net PPE $24.22M $9.84M $10.28M $10.79M $10.79M
-Gross PPE $24.22M $9.84M $10.28M $17.37M $17.37M
Investments and Advances $915.54M $351.10M $312.82M $364.83M $364.83M
-Available for Sale Securities $772.62M $194.23M $193.54M $196.88M $196.88M
-Long Term Equity Investment $48.45M $42.39M $31.52M $46.50M $46.50M
Financial Assets $29.20M $17.91M $13.53M $15.63M $15.63M
Goodwill and Other Intangible Assets $509.90M $310.79M $318.88M $326.98M $326.98M
-Goodwill $207.86M $101.54M $101.54M $101.54M $101.54M
-Other Intangible Assets $302.04M $209.24M $217.34M $225.44M $225.44M
Non-Current Deferred Assets $104.12M $37.12M $8.47M $8.35M $8.35M
Other Non-Current Assets $46.25M $2.01M $2.71M $1.79M $1.79M
Total Liabilities $1.28B $1.22B $534.78M $543.43M $543.43M
Total Current Liabilities $500.57M $46.74M $40.67M $37.45M $37.45M
Payables $9.25M $14.45M $9.00M $6.23M $6.23M
-Accounts Payable $4.10M $9.41M $5.26M $3.24M $3.24M
-Total Tax Payable $5.16M $5.04M $3.73M $2.99M $2.99M
Current Accrued Expenses $25.04M $24.79M $25.83M $22.69M $22.69M
Short-Term Debt and Capital Lease Obligation $452.87M $1.08M $1.09M $1.10M $1.10M
-Current Debt $448.31M – – – –
-Current Capital Lease Obligation $4.56M $1.08M $1.09M $1.10M $1.10M
Current Deferred Liabilities $621,000.00 $621,000.00 $621,000.00 $621,000.00 $621,000.00
Other Current Liabilities $5.20M $1.17M $577,000.00 $422,000.00 $422,000.00
Total Non-Current Liabilities $775.13M $1.17B $494.12M $505.98M $505.98M
Long Term Debt and Capital Lease Obligation $701.34M $1.13B $450.89M $450.40M $450.40M
-Long Term Debt $679.91M $1.13B $446.90M $446.19M $446.19M
-Long Term Capital Lease Obligation $21.43M $3.78M $3.99M $4.20M $4.20M
Non-Current Deferred Liabilities $22.40M $21.65M $22.61M $36.02M $36.02M
Other Non-Current Liabilities $51.39M $19.60M $20.61M $19.56M $19.56M
Total Equity $961.76M $967.52M $997.32M $1.02B $1.02B
Stockholders' Equity $961.76M $967.52M $997.32M $1.02B $1.02B
Capital Stock $20,000.00 $20,000.00 $20,000.00 $20,000.00 $20,000.00
-Common Stock $20,000.00 $20,000.00 $20,000.00 $20,000.00 $20,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $403.54M $379.77M $397.17M $400.65M $400.65M
Retained Earnings $554.77M $583.25M $594.74M $608.09M $608.09M
Gains/Losses Not Affecting Retained Earnings $3.44M $4.48M $5.39M $8.46M $8.46M
-Accumulated Depreciation – – – -$6.58M -$6.58M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$27.59M $24.02M $48.69M $49.36M $45.92M
Net cash flow from continuing operations -$27.59M $24.02M $48.69M $49.36M $45.92M
Net Income from Continuing Operations -$28.49M $48.51M -$13.35M $124.45M $44.78M
Gain/Loss from Continuing Operations -$31.84M -$46.12M $46.20M -$171.82M -$121.26M
Depreciation & Depletion & Amortization $10.32M $8.22M $8.22M $33.78M $8.21M
Deferred Tax -$12.49M $12.98M -$13.53M $22.68M $10.57M
Other Non-Cash Items $9.24M -$5.02M $6.18M $4.84M -$745,000.00
Change in Working Capital -$47.59M -$7.00M $5.89M -$12.67M $9.29M
-Change in Receivables -$16.27M -$13.85M $6.41M -$21.74M -$2.09M
-Change in Inventory -$4.25M $3.00M -$4.14M $4.99M $2.77M
-Change in Payables and Accrued Expense -$4.39M $3.25M $2.71M $5.88M $7.35M
-Change In Other Working Capital -$22.68M $600,000.00 $902,000.00 -$1.80M $1.26M
Net cash flow from investing -$877.99M $321.12M -$94.35M -$377.32M -$18.10M
Net Cash Flow from Continuing Investing Activities -$877.99M $321.12M -$94.35M -$377.32M -$18.10M
Net PPE Purchase and Sale -$142,000.00 -$26,000.00 -$228,000.00 -$452,000.00 -$9,000.00
Net Intangibles Purchase and Sale -$7.97M -$119,000.00 $6.98M -$601,000.00 $845,000.00
Net Investment Purchase and Sale -$55.01M $321.26M -$101.10M -$363.22M -$14.79M
Financing Cash Flow $4.06M $546.43M -$14.13M $428.22M $8.33M
Net Cash Flow from Continuing Financing Activities $4.06M $546.43M -$14.13M $428.22M $8.33M
Net Issuance Payments Of Debt -$195.80M $699.99M -$7,000.00 $353.63M $6.90M
Net Common Stock Issuance $0.00 – – -$15.00M $0.00
Proceeds from Stock Option Exercised $5.62M $122.70M $7.65M $114.89M $9.30M
Net Other Financing Charges $194.23M -$216.26M -$21.78M -$25.30M -$7.87M
Ending Cash Balance $103.39M $1.01B $115.09M $174.93M $174.93M
Net Change in Cash -$901.52M $891.57M -$59.79M $100.26M $36.14M
Beginning Cash Balance $1.01B $115.09M $174.93M $72.31M $139.38M
Effect of Exchange Rate Changes -$1.79M $39,000.00 -$44,000.00 $2.36M -$590,000.00
Free Cash Flow -$57.60M $21.35M $48.46M $38.05M $45.26M
Net Business Purchase and Sale – – – -$8.39M -$303,000.00
Net Other Investing Changes – – – -$4.66M -$3.85M

Discussion

No comments yet — be the first to weigh in on LGND.

Sign in to join the discussion.

Scroll to Top